Article Text
Abstract
The current ethical and regulatory framework for research is often charged with burdening investigators and impeding socially valuable research. To address these concerns, a growing number of research ethicists argue that informed consent should be adapted to the risks of research participation. This would require less rigorous consent standards in low-risk research than in high-risk research. However, the current discussion is restricted to cases of research in which the risks of research participation are outweighed by the potential clinical benefits for the individual research participant. Furthermore, current proposals do not address the concern that risk-adapted informed consent may result in enrolling participants into research without their autonomous authorisation. In this paper, we show how the standard view of informed consent—consent as autonomous authorisation—can be adapted to risk even when the research does not have a favourable risk-benefit profile for the participant. Our argument has two important implications: first, it implies that current and proposed consent standards are not adequately calibrated to risk and, second, that consent standards also need to be adapted to factors other than risk.
- Autonomy
- Clinical trials
- Rights
- Informed Consent
- Research Ethics
Statistics from Altmetric.com
Linked Articles
- The concise argument
Other content recommended for you
- Informed consent to HIV cure research
- Understanding, interests and informed consent: a reply to Sreenivasan
- Limits to research risks
- Risk, double effect and the social benefit requirement
- The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent
- Informed consent for functional MRI research on comatose patients following severe brain injury: balancing the social benefits of research against patient autonomy
- Uninformed refusals: objections to enrolment in clinical trials conducted under an Exception from Informed Consent for emergency research
- Is best interests a relevant decision making standard for enrolling non-capacitated subjects into clinical research?
- Ethics, human rights and HIV vaccine trials in low-income settings
- Phase 1 oncology trials and informed consent